TytoCare Wins First-Of-Its-Kind FDA Approval For AI Ear Diagnostic Tool
Israel's TytoCare receives first-of-its-kind FDA authorization for its AI ear diagnostic tool, Tyto Insights ENT Suite, detecting infection signs.
Israel's TytoCare receives first-of-its-kind FDA authorization for its AI ear diagnostic tool, Tyto Insights ENT Suite, detecting infection signs.
IceCure Medical's ProSense cryoablation, a minimally invasive breast cancer treatment, is now under FDA review in a post-market study called "ChoICE.".
Israeli company Pulsenmore secures its first U.S. client, the Center for Fetal Medicine in Los Angeles, following FDA clearance for its home pregnancy.
Israeli Trisol Medical's innovative tricuspid valve replacement system shows promising U.S. trial outcomes for severe heart conditions, improving patient.
Aidoc's Israeli AI receives FDA clearance for a multi-condition solution, speeding up emergency care by analyzing over 100 million patient cases and improving.
Israeli MedTech firm Bendit secures FDA approval for its revolutionary Bendit17 Microcatheter, enhancing precision in complex vascular procedures.
Israeli MedTech Firm IceCure gains Swiss approval for revolutionary cryoablation cancer therapy, expanding global reach with innovative treatment options.
FDA approves Israel-Developed Delphi-MD, revolutionizing brain assessment with cutting-edge technology from QuantalX Neuroscience.